Feb 11, 2023 | ADHD, Newsletter, Telepsychiatry
The United States has experienced widespread shortages of Attention Deficit Hyperactivity Disorder (ADHD) medications in recent months, resulting in difficulties for patients struggling with ADHD who rely on these drugs to manage their conditions. In August, Adderall,...
